Mirae Asset Global Investments
IBRX icon

Mirae Asset Global Investments’s ImmunityBio IBRX Stock Holding History

Mirae Asset Global Investments’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Sell
46,842
-6,784
-13% -$51.3K ﹤0.01% 1017
2026
Q1 		$411K Buy
53,626
+5,763
+12% +$39.5K ﹤0.01% 973
2025
Q4 		$94.8K Buy
47,863
+11,319
+31% +$25.6K ﹤0.01% 1268
2025
Q3 		$89.9K Buy
36,544
+2,449
+7% +$6.31K ﹤0.01% 1236
2025
Q2 		$90K Buy
34,095
+9,663
+40% +$26K ﹤0.01% 1159
2025
Q1 		$76.7K Buy
24,432
+1,211
+5% +$3.67K ﹤0.01% 1159
2024
Q4 		$64.6K Sell
23,221
-1,971
-8% -$8.21K ﹤0.01% 1229
2024
Q3 		$99K Buy
25,192
+4,545
+22% +$21K ﹤0.01% 1184
2024
Q2 		$135K Sell
20,647
-38,764
-65% -$256K ﹤0.01% 1105
2024
Q1 		$319K Buy
59,411
+17,549
+42% +$79.5K ﹤0.01% 2085
2023
Q4 		$210K Buy
41,862
+31,143
+291% +$97.7K ﹤0.01% 2320
2023
Q3 		$18.1K Sell
10,719
-21,870
-67% -$43.9K ﹤0.01% 2564
2023
Q2 		$90.6K Buy
32,589
+5,815
+22% +$16.4K ﹤0.01% 2540
2023
Q1 		$48.7K Sell
26,774
-24,669
-48% -$76.7K ﹤0.01% 2512
2022
Q4 		$261K Sell
51,443
-7,231
-12% -$39.7K ﹤0.01% 2209
2022
Q3 		$292K Sell
58,674
-13,003
-18% -$59.3K ﹤0.01% 2176
2022
Q2 		$2.34M Buy
71,677
+48,770
+213% +$196K 0.01% 1094
2022
Q1 		$129K Buy
22,907
+6,896
+43% +$42.3K ﹤0.01% 1556
2021
Q4 		$98K Buy
+16,011
New +$120K ﹤0.01% 1550

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 14.43% 1-Year Est. Return
KA
Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's IBRX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its ImmunityBio (IBRX) stake by 13% in Q2 2026, selling an estimated $51.3K and leaving 46,842 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Mirae Asset Global Investments first reported a position in IBRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.34M in Q2 2022. 214 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Mirae Asset Global Investments held 46,842 shares of ImmunityBio worth $410K as of Q2 2026.
  • Mirae Asset Global Investments sold 6,784 ImmunityBio shares in Q2 2026, an estimated $51.3K.
  • ImmunityBio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1017 holding.
  • Mirae Asset Global Investments first reported a position in ImmunityBio in Q4 2021 and has held it in 19 quarters since.
  • Mirae Asset Global Investments's ImmunityBio position peaked at $2.34M in Q2 2022.
  • 214 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.